Postmarket Safety Surveillance of FDA-Cleared Prescription Digital Therapeutics Using the Manufacturer and User Facility Device Experience (MAUDE) Database: A Pharmacovigilance Study
Background and aim Prescription digital therapeutics (PDTs) are software-based medical treatments authorized by the U.S. Food and Drug Administration (FDA) for a range of chronic conditions. As clinical adoption increases,…
Suggested reading